Brief: PharmaSGP FY Adjusted EBIT Down At EUR 16.5 Mln

PharmaSGP Holding SE

31/03/2021 06:38

March 31 (Reuters) - PHARMASGP HOLDING SE  PSGG.DE :
    * FY REVENUE ROSE 1.1 PERCENT TO 63.2 MILLION EUR
    * AT EUR 63.2 MILLION, FY GROUP REVENUE SHOWED SLIGHT GROWTH
IN A
MARKET ENVIRONMENT SEVERELY IMPACTED BY COVID-19
    * FY ADJUSTED EBIT WITH EUR 16.5 MILLION BELOW PREVIOUS YEAR
DRIVEN BY COVID-19 IMPACT; ADJUSTED EBIT MARGIN AT 26.1%
    * FORECAST 2021: REVENUE OF EUR 56-60 MILLION, WITH ADJUSTED
EBIT
MARGIN INCREASING TO 27-30% EXCLUDING EFFECTS FROM POSSIBLE
ACQUISITIONS

Source text for Eikon:  ID:nEQ2YRwgca 
Further company coverage:  PSGG.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))